Summary: H.R.5854 — 113th Congress (2013-2014)All Information (Except Text)

There is one summary for H.R.5854. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (12/11/2014)

Amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in it or in the Public Health Service Act shall prevent or restrict, and the Food and Drug Administration (FDA) shall not implement or enforce any law to prevent or restrict, the importation, distribution, or sale of investigational drugs or devices for terminally ill patients.